Bone Mineral Density in Children With Graves' Disease

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06375096

Enrollment

100

Registered

2024-04-19

Start date

2024-06-25

Completion date

2025-06-25

Last updated

2024-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Density, Low, Bone Mineral Density in Children With Graves' Disease

Brief summary

to evaluate bone mineral density in children with graves' disease

Interventions

OTHERevaluate bone mineral density

observation effect of graves' in bone mineral density in children

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

2 Years to 18 Years

Inclusion criteria

* age at enrollment ≥2 years to \< 18 years * both sexes * the patients should be diagnosed with graves'

Exclusion criteria

* patients less than 2 years * patients more than 18 years * Controlled GD patients on antithyroid * patients with other endocrine diseases

Design outcomes

Primary

Measure	Time frame	Description
bone mineral density	1 month	measure bone mineral density in children diagnosed with graves' disease, to evaluate the effect of the disease on it and the effect of antithyroid medication after that

Contacts

Primary ContactHadeer Youssef Mahmoud

hadeeryoussef754@gmail.com01110548137

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026